132 related articles for article (PubMed ID: 3876055)
21. Long-term (5-11 years) follow-up of general immune competence in breast cancer. I. Pre-treatment levels with reference to micrometastasis.
Shukla HS; Hughes LE; Whitehead RH; Newcombe RG
Cancer Immunol Immunother; 1986; 21(1):1-5. PubMed ID: 3632914
[TBL] [Abstract][Full Text] [Related]
22. Correlations among cutaneous reactivity to DNCB, PHA-induced lymphocyte blastogenesis and peripheral blood E rosettes.
Catalona WJ; Tarpley JL; Potvin C; Chretien PB
Clin Exp Immunol; 1975 Feb; 19(2):327-33. PubMed ID: 1082390
[TBL] [Abstract][Full Text] [Related]
23. [Circulating immune complexes and immunologic reactivity in breast cancer].
Bilynskiĭ BT; Loginskiĭ VE; Fetsich TG
Eksp Onkol; 1984; 6(3):50-2. PubMed ID: 6333978
[TBL] [Abstract][Full Text] [Related]
24. Delayed cutaneous hypersensitivity ad peripheral blood lymphocyte counts in gastrointestinal cancer.
Gupta S; Seth SK; Udupa KN; Sen PC
Ann Acad Med Singap; 1980 Jan; 9(1):71-6. PubMed ID: 7447383
[TBL] [Abstract][Full Text] [Related]
25. Reduced mitogenic stimulation of peripheral blood mononuclear cells as a prognostic parameter for the course of breast cancer: a prospective longitudinal study.
Wiltschke C; Krainer M; Budinsky AC; Berger A; Müller C; Zeillinger R; Speiser P; Kubista E; Eibl M; Zielinski CC
Br J Cancer; 1995 Jun; 71(6):1292-6. PubMed ID: 7779726
[TBL] [Abstract][Full Text] [Related]
26. Humoral and cell-mediated immunity in growth hormone-deficient children: effect of therapy with human growth hormone.
Abbassi V; Bellanti JA
Pediatr Res; 1985 Mar; 19(3):299-301. PubMed ID: 3982890
[TBL] [Abstract][Full Text] [Related]
27. Delayed cutaneous hypersensitivity and peripheral lymphocyte counts in patients with advanced cancer.
Lee YT; Sparks FC; Eilber FR; Morton DL
Cancer; 1975 Mar; 35(3):748-55. PubMed ID: 1111942
[TBL] [Abstract][Full Text] [Related]
28. Clinical studies on cell-mediated immunity in gestational trophoblastic disease: nonspecific cellular immunocompetence in patients with hydatid mole and trophoblastic neoplasia.
Sasaki T; Fujisaki S
Microbiol Immunol; 1981; 25(4):387-401. PubMed ID: 6265741
[TBL] [Abstract][Full Text] [Related]
29. Cimetidine does not influence cellular immunity in patients with chronic renal insufficiency.
Giacchino F; Segoloni G; Giachino G; Jeantet A; Pellerey M; Vercellone A; Piccoli G
Immunol Lett; 1983 Jun; 6(6):303-7. PubMed ID: 6605307
[TBL] [Abstract][Full Text] [Related]
30. Prognistic relevance of radiation induced immune suppression in breast carcinoma.
Baral E; Blomgren H; Ideström K; Wallgren A; Ogenstad S; Petrini B; Silfverswärd C; Wasserman J
Acta Radiol Oncol Radiat Phys Biol; 1979; 18(4):313-20. PubMed ID: 525447
[TBL] [Abstract][Full Text] [Related]
31. Sequential evaluation of immunoreactivity in patients with melanoma undergoing surgery and adjuvant therapy.
Dionigi R; Dominioni L; Gnes F; Bonera A; Prati U; Scarponi A; Robustelli Della Cuna G; Pavesi L; Campani M
Tumori; 1980 Feb; 66(1):59-76. PubMed ID: 6966434
[TBL] [Abstract][Full Text] [Related]
32. Immunocompetence in lung cancer. Relationship to extent of tumor burden and histologic type.
Pillai MR; Balaram P; Padmanabhan TK; Abraham T; Hareendran NK; Nair MK
Cancer; 1989 Nov; 64(9):1853-8. PubMed ID: 2551475
[TBL] [Abstract][Full Text] [Related]
33. Immunologic tools to decipher efficacy of BCG immunotherapy in advanced breast cancer: a one year follow up study.
Saha K; Kapila H; Madan R; Shinghal RN
Asian Pac J Allergy Immunol; 1986 Dec; 4(2):139-48. PubMed ID: 3541948
[TBL] [Abstract][Full Text] [Related]
34. An examination of the immunology of cancer patients.
Cochran AJ; Mackie RM; Grant RM; Ross CE; Connell MD; Sandilands G; Whaley K; Hoyle DE; Jackson AM
Int J Cancer; 1976 Sep; 18(3):298-309. PubMed ID: 783052
[TBL] [Abstract][Full Text] [Related]
35. Delayed type hypersensitivity response to recall antigens does not accurately reflect immune competence in advanced stage breast cancer patients.
Schiffman K; Rinn K; Disis ML
Breast Cancer Res Treat; 2002 Jul; 74(1):17-23. PubMed ID: 12150448
[TBL] [Abstract][Full Text] [Related]
36. Study of B and T lymphocyte surface markers in breast cancer patients using anti-B and anti-T cell monoclonal antibodies.
Nowak JS; Lanzrein C
Neoplasma; 1984; 31(3):281-9. PubMed ID: 6610835
[TBL] [Abstract][Full Text] [Related]
37. Immunosuppression and alterations of T-lymphocyte subpopulations after rubella vaccination.
Arneborn P; Biberfeld G; Wasserman J
Infect Immun; 1980 Jul; 29(1):36-41. PubMed ID: 6967455
[TBL] [Abstract][Full Text] [Related]
38. [Evaluation of T- and B-cell immunity of regional lymph nodes in patients with skin melanoma and prognosis of the disease].
Serov AA; Kadagidze ZG
Vopr Onkol; 1983; 29(12):18-20. PubMed ID: 6607569
[TBL] [Abstract][Full Text] [Related]
39. [Immune system in pregnant women exposed to extreme climate conditions of the Aral coast line].
Atanizova OA; Matveeva NK; Kurbanov AB; Abdirov ChA; Ponomareva IV
Akush Ginekol (Mosk); 1995; (1):26-8. PubMed ID: 7762745
[TBL] [Abstract][Full Text] [Related]
40. [Double urologic tumors: reduced immunocompetence?].
Klippel KF; Hutschenreiter G; Jacobi G; Graff J
Onkologie; 1979 Feb; 2(1):12-6. PubMed ID: 392364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
